Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours

por Fumoleau, Pierre, Trigo, Jose Manuel, Isambert, Nicolas, Sémiond, Dorothée, Gupta, Sunil, Campone, Mario
Publicado 2013

Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

por Isambert, Nicolas, Fumoleau, Pierre, Paul, Catherine, Ferrand, Christophe, Zanetta, Sylvie, Bauer, Jacques, Ragot, Kevin, Lizard, Gérard, Jeannin, Jean-François, Bardou, Marc
Publicado 2013

Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy

por Schmitt, Esther, Végran, Frédérique, Chevrier, Sandy, Burillier, Laura, Cadouot, Muriel, Lizard-Nacol, Sarab, Coudert, Bruno, Fumoleau, Pierre, Arnould, Laurent, Boidot, Romain
Publicado 2015

S’adapter face à la pandémie SARS-CoV2 : l’expérience de l’Institut Curie

por Lucchi-Angellier, Elisabeth, Mino, Jean-Christophe, Burnod, Alexis, Cottu, Paul, Bozec, Laurence, Escalup, Laurence, Massing, Louise, Papon, Marc, Rizand, Philippe, Fumoleau, Pierre, Bouleuc, Carole
Publicado 2021

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study

por Diéras, Véronique, Bachelot, Thomas, Campone, Mario, Isambert, Nicolas, Joly, Florence, Le Tourneau, Christophe, Cassier, Philippe, Bompas, Emmanuelle, Fumoleau, Pierre, Noal, Sabine, Orsini, Christine, Jimenez, Marta, Imbs, Diane Charlotte, Chatelut, Etienne
Publicado 2016

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model

por Bellaye, Pierre-Simon, Oudot, Alexandra, Vrigneaud, Jean-Marc, Raguin, Olivier, Bichat, Francis, Vaslin, Anne, Maby-El Hajjami, Hélène, Zanna, Claudio, Vuagniaux, Grégoire, Fumoleau, Pierre, Denat, Franck, Brunotte, François, Collin, Bertrand
Publicado 2018

FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST

por Depardon, Edouard, Kanoun, Salim, Humbert, Olivier, Bertaut, Aurélie, Riedinger, Jean-Marc, Tal, Ilan, Vrigneaud, Jean-Marc, Lasserre, Maud, Toubeau, Michel, Berriolo-Riedinger, Alina, Dygai-Cochet, Inna, Fumoleau, Pierre, Brunotte, François, Cochet, Alexandre
Publicado 2018

The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubici...

por Penault-Llorca, Frédérique, Filleron, Thomas, Asselain, Bernard, Baehner, Frederick L., Fumoleau, Pierre, Lacroix-Triki, Magali, Anderson, Joseph M., Yoshizawa, Carl, Cherbavaz, Diana B., Shak, Steven, Roca, Lise, Sagan, Christine, Lemonnier, Jérôme, Martin, Anne-Laure, Roché, Henri
Publicado 2018

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy

por Strasser-Weippl, Kathrin, Horick, Nora, Smith, Ian E, O’Shaughnessy, Joyce, Ejlertsen, Bent, Boyle, Frances, Buzdar, Aman U, Fumoleau, Pierre, Gradishar, William, Martin, Miguel, Moy, Beverly, Piccart-Gebhart, Martine, Pritchard, Kathleen I, Lindquist, Deborah, Rappold, Erica, Finkelstein, Dianne M, Goss, Paul E
Publicado 2015

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

por Eliade, Marie, Skrzypski, Jeremy, Baurand, Amandine, Jacquot, Caroline, Bertolone, Geoffrey, Loustalot, Catherine, Coutant, Charles, Guy, France, Fumoleau, Pierre, Duffourd, Yannis, Arnould, Laurent, Delignette, Alexandra, Padéano, Marie-Martine, Lepage, Côme, Raichon-Patru, Géraldine, Boudrant, Axelle, Bône-Lépinoy, Marie-Christine, Villing, Anne-Laure, Charpin, Aurélie, Peignaux, Karine, Chevrier, Sandy, Vegran, Frédérique, Ghiringhelli, François, Boidot, Romain, Sevenet, Nicolas, Lizard, Sarab, Faivre, Laurence
Publicado 2016

GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients

por Cox, David G., Curtit, Elsa, Romieu, Gilles, Fumoleau, Pierre, Rios, Maria, Bonnefoi, Hervé, Bachelot, Thomas, Soulié, Patrick, Jouannaud, Christelle, Bourgeois, Hugues, Petit, Thierry, Tennevet, Isabelle, Assouline, David, Mathieu, Marie-Christine, Jacquin, Jean-Philippe, Lavau-Denes, Sandrine, Darut-Jouve, Ariane, Ferrero, Jean-Marc, Tarpin, Carole, Lévy, Christelle, Delecroix, Valérie, Trillet-Lenoir, Véronique, Cojocarasu, Oana, Meunier, Jérôme, Pierga, Jean-Yves, Faure-Mercier, Céline, Blanché, Hélène, Sahbatou, Mourad, Boland, Anne, Bacq, Delphine, Besse, Céline, Deleuze, Jean-François, Pauporté, Iris, Thomas, Gilles, Pivot, Xavier
Publicado 2016

Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort

por Pivot, Xavier, Romieu, Gilles, Fumoleau, Pierre, Rios, Maria, Bonnefoi, Hervé, Bachelot, Thomas, Soulié, Patrick, Jouannaud, Christelle, Bourgeois, Hugues, Petit, Thierry, Tennevet, Isabelle, Assouline, David, Mathieu, Marie-Christine, Jacquin, Jean-Philippe, Lavau-Denes, Sandrine, Darut-Jouve, Ariane, Ferrero, Jean-Marc, Tarpin, Carole, Lévy, Christelle, Delecroix, Valérie, Trillet-Lenoir, Véronique, Cojocarasu, Oana, Meunier, Jérôme, Pierga, Jean-Yves, Agostini, Cécile, Kerbrat, Pierre, Faure-Mercier, Céline, Blanché, Hélène, Sahbatou, Mourad, Boland, Anne, Bacq, Delphine, Besse, Céline, Calvo, Fabien, Renaud, Alexia, Deleuze, Jean-François, Pauporté, Iris, Thomas, Gilles, Cox, David G.
Publicado 2017

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-path...

por Curtit, Elsa, Pivot, Xavier, Henriques, Julie, Paget-Bailly, Sophie, Fumoleau, Pierre, Rios, Maria, Bonnefoi, Hervé, Bachelot, Thomas, Soulié, Patrick, Jouannaud, Christelle, Bourgeois, Hugues, Petit, Thierry, Tennevet, Isabelle, Assouline, David, Mathieu, Marie-Christine, Jacquin, Jean-Philippe, Lavau-Denes, Sandrine, Darut-Jouve, Ariane, Ferrero, Jean-Marc, Tarpin, Carole, Lévy, Christelle, Delecroix, Valérie, Trillet-Lenoir, Véronique, Cojocarasu, Oana, Meunier, Jérôme, Pierga, Jean-Yves, Kerbrat, Pierre, Faure-Mercier, Céline, Blanché, Hélène, Sahbatou, Mourad, Boland, Anne, Bacq, Delphine, Besse, Céline, Thomas, Gilles, Deleuze, Jean-François, Pauporté, Iris, Romieu, Gilles, Cox, David G.
Publicado 2017

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

por Ferrari, Anthony, Vincent-Salomon, Anne, Pivot, Xavier, Sertier, Anne-Sophie, Thomas, Emilie, Tonon, Laurie, Boyault, Sandrine, Mulugeta, Eskeatnaf, Treilleux, Isabelle, MacGrogan, Gaëtan, Arnould, Laurent, Kielbassa, Janice, Le Texier, Vincent, Blanché, Hélène, Deleuze, Jean-François, Jacquemier, Jocelyne, Mathieu, Marie-Christine, Penault-Llorca, Frédérique, Bibeau, Frédéric, Mariani, Odette, Mannina, Cécile, Pierga, Jean-Yves, Trédan, Olivier, Bachelot, Thomas, Bonnefoi, Hervé, Romieu, Gilles, Fumoleau, Pierre, Delaloge, Suzette, Rios, Maria, Ferrero, Jean-Marc, Tarpin, Carole, Bouteille, Catherine, Calvo, Fabien, Gut, Ivo Glynne, Gut, Marta, Martin, Sancha, Nik-Zainal, Serena, Stratton, Michael R., Pauporté, Iris, Saintigny, Pierre, Birnbaum, Daniel, Viari, Alain, Thomas, Gilles
Publicado 2016

Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome

por Scholl, Suzy, Popovic, Marina, de la Rochefordiere, Anne, Girard, Elodie, Dureau, Sylvain, Mandic, Aljosa, Koprivsek, Katarina, Samet, Nina, Craina, Marius, Margan, Madalin, Samuels, Sanne, Zijlmans, Henry, Kenter, Gemma, Hillemanns, Peter, Dema, Sorin, Dema, Alis, Malenkovic, Goran, Djuran, Branislav, Floquet, Anne, Garbay, Delphine, Guyon, Frédéric, Colombo, Pierre Emmanuel, Fabbro, Michel, Kerr, Christine, Ngo, Charlotte, Lecuru, Fabrice, Campo, Eleonor Rivin del, Coutant, Charles, Marchal, Frédéric, Mesgouez-Nebout, Nathalie, Fourchotte, Virginie, Feron, Jean Guillaume, Morice, Philippe, Deutsch, Eric, Wimberger, Pauline, Classe, Jean-Marc, Gleeson, Noreen, von der Leyen, Heiko, Minsat, Mathieu, Dubot, Coraline, Gestraud, Pierre, Kereszt, Attila, Nagy, Istvan, Balint, Balazs, Berns, Els, Jordanova, Ekaterina, Saint-Jorre, Nicolas de, Savignoni, Alexia, Servant, Nicolas, Hupe, Philippe, de Koning, Leanne, Fumoleau, Pierre, Rouzier, Roman, Kamal, Maud
Publicado 2019

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’

por Scholl, Suzy, Popovic, Marina, Rochefordiere, Anne de la, Girard, Elodie, Dureau, Sylvain, Mandic, Aljosa, Koprivsek, Katarina, Samet, Nina, Craina, Marius, Margan, Madalin, Samuels, Sanne, Zijlmans, Henry, Kenter, Gemma, Hillemanns, Peter, Dema, Sorin, Dema, Alis, Malenkovic, Goran, Djuran, Branislav, Floquet, Anne, Garbay, Delphine, Guyon, Frédéric, Colombo, Pierre Emmanuel, Fabbro, Michel, Kerr, Christine, Ngo, Charlotte, Lecuru, Fabrice, del Campo, Eleonor Rivin, Coutant, Charles, Marchal, Frédéric, Mesgouez-Nebout, Nathalie, Fourchotte, Virginie, Feron, Jean Guillaume, Morice, Philippe, Deutsch, Eric, Wimberger, Pauline, Classe, Jean-Marc, Gleeson, Noreen, Leyen, Heiko von der, Minsat, Mathieu, Dubot, Coraline, Gestraud, Pierre, Kereszt, Attila, Nagy, Istvan, Balint, Balazs, Berns, Els, Jordanova, Ekaterina, de Saint-Jorre, Nicolas, Savignoni, Alexia, Servant, Nicolas, Hupe, Philippe, de Koning, Leanne, Fumoleau, Pierre, Rouzier, Roman, Kamal, Maud
Publicado 2020